As of October, venture capital investments in New York-based health companies using AI have already surpassed $1 billion, up from $670 million in 2023.
Robert Garrett, CEO of Hackensack Meridian Health, discusses the transformative potential of AI in healthcare and leveraging technology to meet the evolving needs of patients and providers.
The company, which provides support to diabetes patients, plans to use the funding to further develop its products.
The number of five-star Medicare Advantage contracts plummeted from 74 in 2022 to just seven for the 2025 plan year. Open enrollment starts Tuesday.
Sponsored Content